): The Pediatric Oncology Fellowship Program at the University of Colorado Health Sciences Center (UCHSC) and Denver Children's Hospital, has a distinguished history spanning over 25 years. In 1993, substantial new resources were dedicated to the development of this Program, leading to the establishment of a Bone Marrow Transplant unit, Neuro-oncology service, and a core group of basic scientists. In addition, the fellowship program was expanded and fellows were given the opportunity to perform research in any laboratory in the UCHSC system. P r esently 23 Training Faculty represent a broad range of scientific disciplines including cell cycle control and signaling, transcriptional regulation and splicing, virology, and immunology. These diverse disciplines and approaches are unified by use of molecular approaches to address fundamental biological questions, and by their applicability to problems in oncology research. Because of the breadth of the clinical experience, the fine clinical reputation of the Children's Hospital, and the new research opportunities available, fellowship candidates since 1993 have consistently increased in quality and dedication to an academic career. The minimal fellowship duration is three years, with the first year exclusively clinical training. Currently there are 10 fellows in the Program, all of whom have previously completed their Pediatric residencies, with 9 in research training beyond their first clinical fellowship year. This proposal seeks funding for those fellows who elect to pursue research related to Pediatric Oncology in the second and third years of the fellowship. Although a new application, both history and recent developments mark this training program as one of the best in the nation. Indeed since 1982, 17 of 25 fellows from this Program have entered academic medicine careers.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Program Officer
Eckstein, David J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Colorado Denver
Schools of Medicine
United States
Zip Code
Loi, Michele M; Kelher, Marguerite; Dzieciatkowska, Monika et al. (2018) A comparison of different methods of red blood cell leukoreduction and additive solutions on the accumulation of neutrophil-priming activity during storage. Transfusion 58:2003-2012
Minson, Katherine A; Smith, Catherine C; DeRyckere, Deborah et al. (2016) The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia. JCI Insight 1:e85630
Bhatla, Teena; Dandekar, Smita; Lu, Benjamin Y et al. (2016) Genomic Characterization of Poorly Differentiated Neuroendocrine Carcinoma in a Pediatric Patient. J Pediatr Hematol Oncol 38:e21-5
Ye, Haobin; Adane, Biniam; Khan, Nabilah et al. (2016) Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche. Cell Stem Cell 19:23-37
Stevens, Brett; Maxson, Julia; Tyner, Jeffrey et al. (2016) Clonality of neutrophilia associated with plasma cell neoplasms: report of a SETBP1 mutation and analysis of a single institution series. Leuk Lymphoma 57:927-34
Hudish, Laura I; Galati, Domenico F; Ravanelli, Andrew M et al. (2016) miR-219 regulates neural progenitors by dampening apical Par protein-dependent Hedgehog signaling. Development 143:2292-304
Pei, Shanshan; Minhajuddin, Mohammad; D'Alessandro, Angelo et al. (2016) Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells. J Biol Chem 291:21984-22000
Riedel, Simone S; Haladyna, Jessica N; Bezzant, Matthew et al. (2016) MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia. J Clin Invest 126:1438-50
Ho, Tzu-Chieh; LaMere, Mark; Stevens, Brett M et al. (2016) Evolution of acute myelogenous leukemia stem cell properties after treatment and progression. Blood 128:1671-8
Gump, Jacob M; Donson, Andrew M; Birks, Diane K et al. (2015) Identification of targets for rational pharmacological therapy in childhood craniopharyngioma. Acta Neuropathol Commun 3:30

Showing the most recent 10 out of 86 publications